Heron Therapeutics Inc (LTS:0J4V) Transcripts
Q3 2024 Heron Therapeutics Inc Earnings Call Transcript
Nov 12, 2024
$1.3
(-29.34%)
Earnings
Q2 2024 Heron Therapeutics Inc Earnings Call Transcript
Aug 06, 2024
$2.71
(+2.42%)
Earnings
Q1 2024 Heron Therapeutics Inc Earnings Call Transcript
May 07, 2024
$2.73
(+1.11%)
Earnings
Q4 2023 Heron Therapeutics Inc Earnings Call Transcript
Mar 12, 2024
$2.44
(-1.81%)
Earnings
Q3 2023 Heron Therapeutics Inc Earnings Call Transcript
Nov 14, 2023
$0.60182
(+10.93%)
Earnings
Q2 2023 Heron Therapeutics Inc Earnings Call Transcript
Aug 14, 2023
$1.51
(-10.65%)
Earnings
Q1 2023 Heron Therapeutics Inc Earnings Call Transcript
May 11, 2023
$2.29
(-5.93%)
Earnings
Heron Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 20, 2023
Q4 2022 Heron Therapeutics Inc Earnings Call Transcript
Mar 23, 2023
$2.1
(+4.48%)
Earnings
Q3 2022 Heron Therapeutics Inc Earnings Call Transcript
Nov 08, 2022
$3.42
Earnings
Heron Therapeutics Inc Investor Call Transcript
Sep 19, 2022
Q2 2022 Heron Therapeutics Inc Earnings Call Transcript
Aug 09, 2022
$4.18
(+18.19%)
Earnings
Q1 2022 Heron Therapeutics Inc Earnings Call Transcript
May 09, 2022
$4.74
Earnings
Heron Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 11, 2022
Q4 2021 Heron Therapeutics Inc Earnings Call Transcript
Feb 28, 2022
$7.17
Earnings
Heron Therapeutics Inc Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF Transcript
Dec 09, 2021
Q3 2021 Heron Therapeutics Inc Earnings Call Transcript
Nov 03, 2021
$11.14
Earnings
Heron Therapeutics Inc to Host U.S. FDA Approval of ZYNRELEFâ„¢ - Conference Call Transcript
May 13, 2021
Heron Therapeutics Inc 2020 Conference Call Transcript
Jun 29, 2020
Heron Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 17, 2020
Heron Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Oct 02, 2019
Heron Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
Heron Therapeutics Inc to discuss the Complete Response Letter - Conference Call Transcript
May 01, 2019